Literature DB >> 25880796

Bilirubin production and hour-specific bilirubin levels.

V K Bhutani1, R J Wong1, H J Vreman1, D K Stevenson1.   

Abstract

OBJECTIVE: We assessed the relative contributions of increased bilirubin production (indexed by end-tidal carbon monoxide (CO) concentrations, corrected for ambient CO (ETCOc)) to hour-specific total bilirubin (TB) levels in healthy late preterm and term newborns. STUDY
DESIGN: Post hoc analyses of concurrent ETCOc and TB (at 30±6 h of age) and follow-up TB levels at age 96±12 h and up to 168 h after birth were performed in a cohort of 641 term and late preterm infants.
RESULTS: Increased bilirubin production (hour-specific ETCOc ⩾1.7 p.p.m. at age 30±6 h) was noted in ~80%, 42% and 32% of infants in the high-, intermediate- and low-risk TB zones, respectively. One infant with TB <40th percentile and ETCOc <1.7 p.p.m. developed TB ⩾95th percentile at age 168 h, probably due to decreased bilirubin elimination.
CONCLUSIONS: Infants in the high-risk quartile of the hour-specific bilirubin nomogram have a higher mean bilirubin production. Infants with TB levels ⩾95th percentile without increased bilirubin production have impaired bilirubin elimination.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25880796     DOI: 10.1038/jp.2015.32

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  24 in total

1.  System-based approach to management of neonatal jaundice and prevention of kernicterus.

Authors:  Lois H Johnson; Vinod K Bhutani; Audrey K Brown
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

2.  Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches.

Authors:  R Keren; V K Bhutani; X Luan; S Nihtianova; A Cnaan; J S Schwartz
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

3.  Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization.

Authors:  T B Newman; B Xiong; V M Gonzales; G J Escobar
Journal:  Arch Pediatr Adolesc Med       Date:  2000-11

4.  End-tidal carbon monoxide in newborn infants: observations during the 1st week of life.

Authors:  V Balaraman; S Pelke; S DiMauro; S Cheung; D K Stevenson; D Easa
Journal:  Biol Neonate       Date:  1995

Review 5.  Kernicterus: epidemiological strategies for its prevention through systems-based approaches.

Authors:  Vinod K Bhutani; Lois H Johnson; M Jeffrey Maisels; Thomas B Newman; Ciaran Phibbs; Ann R Stark; Marshalyn Yeargin-Allsopp
Journal:  J Perinatol       Date:  2004-10       Impact factor: 2.521

6.  Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adults.

Authors:  H J Vreman; R J Wong; P Harmatz; A A Fanaroff; B Berman; D K Stevenson
Journal:  J Clin Monit Comput       Date:  1999-12       Impact factor: 2.502

7.  Pulmonary excretion of carbon monoxide in the human newborn infant as an index of bilirubin production: III. Measurement of pulmonary excretion of carbon monoxide after the first postnatal week in premature infants.

Authors:  D K Stevenson; A L Bartoletti; C R Ostrander; J D Johnson
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

8.  Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.

Authors:  Vinod K Bhutani; Ann R Stark; Laura C Lazzeroni; Ronald Poland; Glenn R Gourley; Steve Kazmierczak; Linda Meloy; Anthony E Burgos; Judith Y Hall; David K Stevenson
Journal:  J Pediatr       Date:  2012-10-05       Impact factor: 4.406

9.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  2 in total

1.  Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in Neonates.

Authors:  Wojciech Krzyzanski; Sarah F Cook; Melanie Wilbaux; Catherine M T Sherwin; Karel Allegaert; An Vermeulen; John N van den Anker
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

2.  Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Authors:  V K Bhutani; R Poland; L D Meloy; T Hegyi; A A Fanaroff; M J Maisels
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.